相关实验视频
Updated: Jun 29, 2025

07:34
Milk Collection Methods for Mice and Reeves' Muntjac Deer
Published on: July 19, 2014
19.9K
乳牛中的甲酸的药理动力学
P Bhusal1, M C Lay2, K L Kraakman1
1Ruminant Biotech Corp Limited, Hamilton, New Zealand.
New Zealand veterinary journal
|April 3, 2024
概括
红色海藻中的bromoform是一种抗甲原剂,在奶牛牛中很快被吸收. 它的消除动力学取决于剂量,影响其在牲畜中的使用.
科学领域:
- 兽医药理学 兽医药理学
- 类动物营养 类动物营养
- 海洋天然产品 海洋天然产品
背景情况:
- 形,来自 *Asparagopsis* spp. 的衍生物. 海藻,是牲畜潜在的抗甲原剂.
- 了解其药理动力学对于评估其在乳牛中的有效性和安全性至关重要.
研究的目的:
- 为了确定口服和静脉注射后乳牛中甲酸的药理动力学概况.
- 为了评估型的吸收,分布,新陈代谢和分泌 (ADME) 特性.
主要方法:
- 在第一阶段,24只奶牛母牛接受了逐渐升级的口服剂量 (200-1600毫克) 的甲基.
- 在第二阶段,公牛接收了连续的口服和静脉注射剂量 (50毫克和100毫克),并有72小时的洗期.
- 用气色谱-质谱分析分析了血液样本,以确定形和二甲的度.
主要成果:
- 形呈现出快速吸收,Tmax为15分钟.
- 终端半衰期从0.32到5.73小时不等,取决于剂量和服用途径.
- 观察到不成比例的药理动力学行为和剂量依赖的生物可用性.
结论:
- 形式在奶牛中被迅速吸收,并表现出剂量依赖的排泄动力学.
- 这些发现对于优化甲剂量和用于牛中甲减排的施用策略至关重要.
相关概念视频
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
249
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
249
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
969
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
969
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
450
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
450
Cholinergic Antagonists: Pharmacokinetics
437
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
437
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K

